SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009685
Filing Date
2023-05-15
Accepted
2023-05-15 07:31:29
Documents
59
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20230331x10q.htm   iXBRL 10-Q 983171
2 EX-31.1 zyne-20230331xex31d1.htm EX-31.1 11476
3 EX-31.2 zyne-20230331xex31d2.htm EX-31.2 11213
4 EX-32.1 zyne-20230331xex32d1.htm EX-32.1 6118
5 EX-32.2 zyne-20230331xex32d2.htm EX-32.2 6139
6 GRAPHIC zyne-20230331x10q001.jpg GRAPHIC 51931
  Complete submission text file 0001558370-23-009685.txt   4854049

Data Files

Seq Description Document Type Size
7 EX-101.SCH zyne-20230331.xsd EX-101.SCH 36633
8 EX-101.CAL zyne-20230331_cal.xml EX-101.CAL 37543
9 EX-101.DEF zyne-20230331_def.xml EX-101.DEF 138732
10 EX-101.LAB zyne-20230331_lab.xml EX-101.LAB 290359
11 EX-101.PRE zyne-20230331_pre.xml EX-101.PRE 239531
53 EXTRACTED XBRL INSTANCE DOCUMENT zyne-20230331x10q_htm.xml XML 857612
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 23918401
SIC: 2834 Pharmaceutical Preparations